RECOMBINANT FACTOR VIIa – NEW TREATMENT OPTION FOR CONTROL OF INTRACTABLE BLEEDING IN SURGICAL AND TRAUMA PATIENTS AND IN OTHER HAEMOSTASIS DISORDERS

RECOMBINANT FACTOR VIIa – NEW TREATMENT OPTION FOR CONTROL OF INTRACTABLE BLEEDING IN SURGICAL AND TRAUMA PATIENTS AND IN OTHER HAEMOSTASIS DISORDERS

<p>Background. Recombinant factor VIIa (rFVIIa), which is currently registered only for the treatment of haemophilia A and B patients with inhibitors, is seen increasingly as a possible universal haemostatic agent in untractable bleedings. One possible mechanism for the efficacy rFVIIa may be...

Full description

Bibliographic Details
Main Authors: Samo Zver, Dušan Andoljšek
Format: Article
Language:English
Published: Slovenian Medical Association 2004-12-01
Series:Zdravniški Vestnik
Subjects:
recombinant factor VIIa
haemostasis
bleeding coagulopathy
sindrom of disseminated intravascular coagulation
surgery patient
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2442

Internet

http://vestnik.szd.si/index.php/ZdravVest/article/view/2442

Similar Items